Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: A regional teaching hospital experience

American Surgeon

Volumn 78, Issue 3, 2012, Pages 305-308

  Geraldson, Carl T ^a   Stephenson, James E ^b   Lagrew, James P ^a   Schammel, Christine M ^a   Schammel, David P ^d   Greene, Ryan A ^c   Bolton, William D ^b  

^a FURMAN UNIVERSITY   (United States)

^b GREENVILLE HOSPITAL SYSTEM   (United States)

^c CLEMSON UNIVERSITY   (United States)

^d Pathology Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857540351     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Edge SB, Byrd DR, Compton CC, et al., eds. American Joint Committee on Cancer (AJCC) Staging Manual: Lung, 7th ed. New York: Springer; 2009.
2. Erasmus JJ, Macapinlac HA, Swisher SG. Positron emission tomography imaging in nonsmall-cell lung cancer. Cancer 2007; 110:2155-68. (Pubitemid 350100736)
3. Pieterman RM, van Putten JW,Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254-61. (Pubitemid 30490393)
4. Saunders CA, Dussek JE, O'Doherty MJ, Maisey MN. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 1999;67:790-7. (Pubitemid 29207699)
5. Ettinger DS, AkerleyW, Bepley G, et al. Non-small cell lung cancer. NCCN 2008;6:228-69. (Pubitemid 351488820)
6. Kelly RF, Tran T, Holmstrom A, et al. Accuracy and costeffectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer. Chest 2004;125:1413-23. (Pubitemid 38501358)
7. Darling GE, Maziak DE, Inculet RI, et al. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial. J Thorac Oncol 2011;6:1367-72.
8. Perigaud C, Bridji B, Roussel JC, et al. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer. Eur J Cardiothorac Surg 2009;36: 731-6.
9. Poncelet AJ, Lonneux M, Coche E, et al. PET-FDG scan enhances but does not replace preoperative surgical staging in nonsmall cell lung carcinoma. Eur J Cardiothorac Surg 2001;20:468-74.
10. Taschi E, Tezel C, Orki A, et al. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2010;10:200-3.
11. Hicks RJ, Lau E, Alam NZ, Chen RY. Imaging in the diagnosis and treatment of non-small cell lung cancer. Respirology 2007;12:165-72. (Pubitemid 46239388)